Gujarat Themis Biosyn Limited (BOM:506879)
India · Delayed Price · Currency is INR 390.35
+22.65 (6.16%)
At close: Jul 29, 2025
Gujarat Themis Biosyn Revenue
In the fiscal year ending March 31, 2025, Gujarat Themis Biosyn had annual revenue of 1.51B INR, down -11.20%. Gujarat Themis Biosyn had revenue of 377.36M in the quarter ending March 31, 2025, a decrease of -9.55%.
Revenue
1.51B
Revenue Growth
-11.20%
P/S Ratio
28.25
Revenue / Employee
9.48M
Employees
159
Market Cap
42.60B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1.51B | -190.22M | -11.20% |
| Mar 31, 2024 | 1.70B | 214.37M | 14.45% |
| Mar 31, 2023 | 1.48B | 335.31M | 29.19% |
| Mar 31, 2022 | 1.15B | 242.91M | 26.82% |
| Mar 31, 2021 | 905.63M | 54.38M | 6.39% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,765.41B |
| HDFC Bank | 2,736.06B |
| Bharti Airtel | 1,729.85B |
| Tata Consultancy Services | 2,561.48B |
| ICICI Bank | 2,054.85B |
| State Bank of India | 3,429.39B |
| Infosys | 1,672.76B |
| Hindustan Unilever | 631.21B |
Gujarat Themis Biosyn News
- 3 months ago - Gujarat Themis Biosyn starts commercial production at new API plant in Vapi, Gujarat - Business Upturn
- 9 months ago - Themis Medicare shares surge nearly 2% following amalgamation announcement - Business Upturn